Creation of Transgenic Mice of Dialysis-Related Amyloidosis
Creation of Transgenic Mice of Dialysis-Related Amyloidosis
批准号:
10670990
负责人:
MARUYAMA Hiroki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To clarify the pathogenesis and establish therapy of dialysis-related amyloidosis, , we cloned humanβ_2-M cDNA by RT-PCR.We inserted humanβ_2-M cDNA into unique XhoI site of pCAGGS.We generated transgenic mice overexpressing humanβ_2-M (F0 5 lines). We confirmed humanβ_2-MmRNA by RT-PCR and northern blotting analysis, serum and urine humanβ_2-M by western blotting. We generated homozygote transgenic mice by mating F1. Serum humanβ_2-M levels (20-30mg/l)were as high as those levels in hemodialyzed patients. We could not observe dialysis-related amyloidosis in transgenic mice. These results demonstrated that only hyper β_2-M could not cause dialysis-related amyloidosis. We observe dialysis-related amyloidosis patients with chronic renal failure. To add a crucial factor, chronic renal failure, for development of dialysisrelated amyloidosis, we created five-sixths nephrectomized transgenic mice. We will analyze these mice.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hiroki Maruyama: "Requiring higher doses of erythropoietin suggests pregnancy in hemodialysis patients."Nephron. 79. 413-419 (1998)
Hiroki Maruyama:“需要更高剂量的促红细胞生成素表明血液透析患者怀孕。” 肾单位。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroki Maruyama: "Pre-and postoperative management of patients with destructive spondyloarthropathy."Jpn.J.Clin.Dial.. 14. 83-89 (1998)
Hiroki Maruyama:“破坏性脊柱关节病患者的术前和术后管理。”Jpn.J.Clin.Dial.. 14. 83-89 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumitake Gejyo: "The clinical effect of a β_2-microglobulin adsorption column of direct hemoperfusion Type [Lixelle] on dialysis-related-amyloidosis : A prospective multi-center controlled β_2-microglobulin adsorption column study (βMACS)"Kidney and Trans
Fumitake Gejyo:“直接血液灌流型 [Lixelle] β_2-微球蛋白吸附柱对透析相关淀粉样变性的临床效果:前瞻性多中心控制 β_2-微球蛋白吸附柱研究 (βMACS)” 肾脏和转运
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
丸山弘樹: "Annual review腎臓2001透析アミロイドーシスによる関節症の治療"中外医学社. 251 (2001)
Hiroki Maruyama:“2001 年肾透析淀粉样变性关节病治疗年度回顾”Chugai Igakusha 251 (2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroki Maruyama: "Dialysis-related amyloidosis Review"Kidney and Transplantation. 47. 767-771 (2000)
Hiroki Maruyama:“透析相关淀粉样变性综述”肾脏和移植。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Investigation of pathogenesis of Fabry nephropathy in novel model mouse
-
批准号:23390223
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.48万
-
财政年份:2011
-
负责人:MARUYAMA Hiroki
-
依托单位:
Novel Mutations of the GLA Gene in Japanese Patients with Fabry disease and their functional characterization by active site specific chaperone
-
批准号:18590884
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:MARUYAMA Hiroki
-
依托单位:
Gene therapy for Fabry mice
-
批准号:15590844
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:MARUYAMA Hiroki
-
依托单位:
Kidney-targeted plasmid DNA transfer by retrograde renal vein injection
-
批准号:13671103
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:MARUYAMA Hiroki
-
依托单位: